Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases

Chinese Medical Journal

Volumn 112, Issue 2, 1999, Pages 149-152

  Xue, Yan ^a   Jia, Weiwei ^a   Zhang, Haiwen ^a   Dong, Jieying ^a   Clemens, J Dan ^b   Tian, Xiaoming ^c  

^a Jishuitan Orthopaedic College of Tsinghua University   (China)

^b Ostex International Inc   (United States)

^c NONE

Author keywords

Biochemical markers; Bone turnover; Cross linked; N telopeptides

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGED; OSTEOLYSIS; OSTEOPOROSIS; PREGNANCY; PRESCHOOL CHILD; SEX DIFFERENCE; URINE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE RESORPTION; CHILD; CHILD, PRESCHOOL; COLLAGEN; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES; PREGNANCY; SEX FACTORS;

EID: 0040886088     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gunja-Smith Z, Boueek RJ. Collagen cross-linking compounds in human urine. Biochem J 1981;197:759-762.
2. Hanson DA, Weis MA, Bollen AM, et al. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251-1258.
3. Gordeladze JD, Halse J, Djsoseland O, et al. A simple procedure for the determination of hydroxyproline in urine and bone. Biochem Med 1978;20:23-30.
4. Kanis JA, Melton III J, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
5. Gertz BJ, Shao P, Hanson DA, et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 1994;9:135.
6. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1989; 169:197-203.
7. Kivirikko KI. Urinary excretion of hydroxyproline in health and disease. Int Rev Connect Tissue Res 1970;5:93-163.
8. Beardsworth LJ, Eyre DR, Dickson IR. Changes with age in the urinary excretion of elysyl and hydroxylysylpyridinoline two new markers of bone collagen turnover. J Bone Miner Res 1990;5:671-676.
9. Garnero P, Sornay-Rendu E, Delmas PD. Assessment of age-related changes of bone turnover in normal women with new biochemical markers. J Bone Miner Res 1994;9(Suppl 1):S389.
10. Delmas PD, Schelmmer A, Gineyts E, et al. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639-644.
11. Garnero P, Shih WJ, Gineyts E, et al. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-1700.
12. Rosen HN, Dresner-Pollak R, Moses AC, et al. Specificity of urinary excretion of crosslinked N-telopeptides of type I collagen as a marker of bone turnover. Calif Tissue 1994;54:26-29.
13. 2 on calcium homeostasis in postmenopausal osteopenic women. J Bone Miner Res 1994;9:607-614.
14. Tilyard MW, Spears GFS, Thomso J, et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-362.